Purdue Pharma Marketed Oxycontin As Less Addictive, Despite Known Abuse

Purdue Pharma, maker of OxyContin and lesser known MS Contin, is facing scrutiny after several recent articles exposed information from a Justice Department investigation into the company. The investigation focused on evidence that showed Purdue’s legal council and executives were aware of the addictive nature of their drugs, including their popularity with drug seekers. Despite knowing their drugs were being misused, the company continued a false marketing campaign that promoted the drug as safer than other opioids because it was less likely to be abused or cause addiction. The company still maintains that they weren’t aware of users abusing their drugs until Maine’s attorney general issued an alert about the drug in 2000, despite federal investigators finding proof that company salespeople were aware as early as 1997, just a year after the release of OxyContin. The federal investigation ended in 2007 with Purdue Pharma pleading guilty to a felony charge of…

Read more detail on Recent Medical Malpractice posts –

This entry was posted in Medical malpractice law and tagged , , , , , , , , . Bookmark the permalink.

Leave a Reply